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Abstract
The Avon Longitudinal Study of Parents andBackground: 
Children-Generation 2 (ALSPAC-G2) was set up to provide a unique
multi-generational cohort. It builds on the existing ALSPAC resource, which
recruited 14,541 pregnancies to women resident in the South West of England
who were expected to deliver between 01/04/1991 and 31/12/1992. Those
women and their partners (Generation 0; ALSPAC-G0) and their offspring
(ALSPAC-G1) have been followed for the last 26 years. This profile describes
recruitment and data collection on the next generation (ALSPAC-G2)—the
grandchildren of ALSPAC-G0 and children of ALSPAC-G1.
 Recruitment began on the 6  of June 2012 and we presentRecruitment:
details of recruitment and participants up to 30  June 2018 (~6 years). We
knew at the start of recruitment that some ALSPAC-G1 participants had already
become parents and ALSPAC-G2 is an open cohort; we recruit at any age. We
hope to continue recruiting until all ALSPAC-G1 participants have completed
their families. Up to 30  June 2018 we recruited 810 ALSPAC-G2 participants
from 548 families. Of these 810, 389 (48%) were recruited during their mother’s
pregnancy, 287 (35%) before age 3 years, 104 (13%) between 3-6 years and
30 (4%) after 6 years. Over 70% of those invited to early pregnancy, late
pregnancy, second week of life, 6-, 12- and 24-month assessments (whether
for their recruitment, or a follow-up, visit) have attended, with attendance being
over 60% for subsequent visits up to 7 years (to few are eligible for the 9- and
11-year assessments to analyse).
We collect a wide-range of social, lifestyle, clinical,Data collection: 
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 We collect a wide-range of social, lifestyle, clinical,Data collection: 
anthropometric and biological data on all family members repeatedly. Biological
samples include blood (including cord-blood), urine, meconium and faeces,
and placental tissue. In subgroups detailed data collection, such as continuous
glucose monitoring and videos of parent-child interactions, are being collected.
Keywords
ALSPAC, Birth Cohort, Cross-generation, Data Sharing
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Introduction
Why was the cohort set up?
The Avon Longitudinal Study of Parents and Children-2nd Gen-
eration study (ALSPAC-G2) was set up to provide a unique 
multi-generational family study and to be a resource for interna-
tional researchers to explore the environmental, socioeconomic, 
lifestyle, physiological, metabolic, genomic and epigenomic 
contributions to health and development across the lifecourse 
and across generations. It builds on the existing ALSPAC 
resource which originally recruited 14,541 pregnancies to women 
who were resident in the former county of Avon (centred around 
the city of Bristol in the South West of England) and who were 
expected to deliver between 01/04/1991 and 31/12/1992. Those 
women and their partners (ALSPAC-G0), together with their 
index children (ALSPAC-G1), who are now in their late-20s, have 
been followed since pregnancy or birth, with full details provided 
in previous cohort profiles1,2. The ALSPAC resource, including 
ALSPAC-G2, receives core funding from the University of Bristol, 
Wellcome and UK Medical Research Council, with additional 
support from a very wide range of national and international 
funders (a comprehensive list of grant funding is available on the 
ALSPAC website: http://www.bristol.ac.uk/alspac/external/docu-
ments/grant-acknowledgements.pdf). Since its inception in the 
early 1990s the study has been known by two names. ALSPAC, 
including ALSPAC-G2, is used in all academic publications, 
presentations and with research funders. To participants and in 
the media the original study (specifically ALSPAC-G1) is known 
as Children of the 90s (Co90s) and ALSPAC-G2 is known 
as Children of the Children of the 90s (CoCo90s; sometimes 
abbreviated verbally to CoCos).
It was envisaged that initially ALSPAC-G2 would contribute 
unique research in the following broad areas:
1.    Understanding how socioeconomic, lifestyle, patho- 
physiological, metabolic, genomic and epigenomic fac-
tors combine to influence the associations of health and 
wellbeing across generations. With the addition of 
ALSPAC-G2, ALSPAC is unique in being the only human 
study able to do this with relevant detailed data across 
three generations.
2.    Determining the impact of pre-conceptual health and 
wellbeing of mothers and fathers on fertility and growth, 
development and health of their offspring. The impor-
tance of pre-conceptual cohort studies is increasingly 
recognised but they are difficult to establish, with many 
existing pre-conceptual cohorts recruited from fertility 
clinics rather than the general population as here3. For 
ALSPAC-G2 children, we have detailed repeatedly 
assessed preconceptual data for at least one of the parents 
(the original ALSPAC-G1 participant who has become a 
parent). For the second parent who was not originally 
in ALSPAC but is recruited to ALSPAC-G1 as part of 
extending the resource to ALSPAC-G2 we will have pre- 
conceptual data from record linkage and for subse-
quent pregnancies/children (i.e. those recruited after 
the first child that is recruited to ALSPAC-G2) we 
will also have preconceptual data from our research 
clinic. No existing birth cohort has such extensive paren-
tal data, including on fathers, with many having little 
or no data on large proportions of fathers4.
3.    Providing an opportunity to study people who become 
parents at a relatively young age and comparing them 
to couples who become parents at older ages and who 
are from the same birth cohort and born in the same 
geographical area.
4.    Describing environmental (e.g. climate change, air- 
pollution), societal (e.g. different methods of communi-
cation, changing patterns of between and within country 
migration), political (e.g. distrust of experts, departures 
from traditional political parties, changes in gender poli-
tics, retirement age and types of employment) technologi-
cal (e.g. widespread use of information technology and the 
emergence of artificial intelligence) and lifestyle factors 
(e.g. sedentary behaviour, reduced smoking and alcohol 
consumption, increased vaping) that have changed between 
the current generation of young adults (ALSPAC-G1) 
and their parents’ generation (ALSPAC-G0). Explor-
ing the influence of generational differences in exposure 
to these factors on decisions about whether, and when, 
to start a family, parenting patterns, child (ALSPAC-G2) 
development, parental and child mental and physical health 
and ‘work-family/outside of work’ balance.
5.    Exploiting the very detailed genetic and phenotypic data 
collected on parents and siblings to improve causal infer-
ence in research, by triangulating results using different 
methodological approaches, such as Mendelian randomi-
zation, parental negative control studies and within sibship 
analyses5.
6.    Providing a platform for pilot and feasibility studies of 
novel technologies for data collection, such as the use of 
non-intrusive wearables (e.g. biosensors and smart watches) 
for continually monitoring physiology and behaviours.
Who is in the cohort?
We began recruitment to ALSPAC-G2 on the 6th June 2012. We 
aim is to recruit all children of ALSPAC-G1 participants into 
ALSPAC-G2. As well as recruiting the next generation of children, 
we also recruit the (non-ALSPAC) partners of their ALSPAC-G1 
parent and collect data from them (Figure 1). Of the 810 
ALSPAC-G2 pregnancies/children recruited to date both parents 
of 74 (9%) were original ALSPAC-G1 children. Thus, for each 
ALSPAC-G2 pregnancy/child we have very detailed repeatedly 
assessed information on at least one of their parents from when 
that parent was in utero to the time of them becoming pregnant/a 
parent (with this being the case for both parents for 9% of 
ALSPAC-G2). We also have newly collected information from 
questionnaires, clinic assessments, record linkage and blood 
samples (on which genome-wide, epigenetic and metabolomic 
data are being assessed), from both parents, including any 
parent who was not an original ALSPAC-G1 participant, 
but is recruited to be part of ALSPAC-G1 as we recruit their 
ALSPAC-G2 child.
Page 3 of 14
Wellcome Open Research 2019, 4:36 Last updated: 21 FEB 2019
We recruit ALSPAC-G2 participants through multiple means: via 
questionnaires to all ALSPAC-G0 and -G1 participants, in which 
we ask about becoming pregnant or a parent (ALSPAC-G1) 
or a grandparent (ALSPAC-G0); asking similar questions when 
any ALSPAC-G0 or -G1 participant attends a research clinic 
visit; and through posters in primary care clinics and mater-
nity units in the South West of England. We also use our regular 
mailed and emailed newsletters and conventional (e.g. local 
radio and newspapers) and social (e.g. Facebook, Instagram and 
Twitter) media to remind ALSPAC-G0 and -G1 participants 
about ALSPAC-G2. When we hear about an ALSPAC-G1 par-
ticipant becoming pregnant or a parent, from one of their parents 
(ALSPAC-G0) we ask that their parent mention ALSPAC-G2 
to them and ask them to contact us if they are interested in hear-
ing more about the study via an information pack. Similarly, 
when ALSPAC-G1 participants contact us because of hear-
ing about the study via our newsletter or other media, we ask if 
they would like an information pack. Parents of ALSPAC-G2 
participants can be resident anywhere, though the vast majority 
remain in the UK; we offer travel costs to clinic visits in Bristol. 
Biological samples at birth (cord-blood and placental tissue) 
are currently collected on participants delivering at one of nine 
maternity units in and around the South West of England.
Ethics. Ethical approval for ALSPAC was obtained from the 
ALSPAC Ethics and Law Committee and the UK National Health 
Service Research Ethics Committee (full details are available at: 
http://www.bristol.ac.uk/alspac/researchers/data-access/ethics/
lrec-approvals/#d.en.164120). Participants (the main care-giver 
for children) provided written informed consent for data collection 
and its use in research.
Response and characteristics of eligible participants who are 
and are not recruited. For all analyses in this profile we have 
restricted the sample to children of any ALSPAC-G1 pregnant/ 
parent participant who agreed to be sent an invitation pack and 
for whom we had a correct address (Figure 2) up to and including 
30/06/2018. This provides just over 6 years of data and means 
we can include all data that has had appropriate quality control 
checks and linkage to the existing ALSPAC-G0 and -G1 data.
Over this period, we have identified 1145 ALSPAC-G1 par-
ticipants who were pregnant, had a partner who was pregnant 
or had become a parent, and we sent invites to 1062 (93%) of 
these, with 596 (56% of those invited) agreeing to participate. By 
30th June 2018 we had assessed and obtained parental consent 
for 810 ALSPAC-G2 children from 548 families (Figure 2). Of 
these 810 ALSPAC-G2 participants 389 (48%) were recruited 
in either early or late pregnancy, with the proportion recruited in 
pregnancy increasing over time from 20% to 63% between the 
first year (6th June 2012 to 30th June 2013) to the most recent 
year (1st July 2017 to 30th June 2018) (Table 1). As might 
be expected, none of the ALSPAC-G2 participants were 
recruited at the 7–15-days assessment; all participants seen at 
7–15-days were recruited in pregnancy. Similarly, none of the 
ALSPAC-G2 participants were recruited at the 11-year assess-
ment; those seen at that age were all recruited at earlier ages 
(Table 1).
Characteristics of those recruited
In analyses using observed data and not taking account of miss-
ing data, eligible ALSPAC-G1 parents/pregnant women who 
were recruited were slightly younger, had higher BMI and were 
more likely to have attended the two most recent clinic assess-
ments (17–18 or 23–24 years) than those who declined or did 
not respond, but were similar in terms of sex, educational attain-
ment and smoking (Table 2). However, there was more missing 
data for these characteristics among those who were not recruited. 
Figure 1. Summarising timing and nature of recruitment to different ALSPAC generations.
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We therefore used multivariable multiple imputation to explore 
the extent to which missing data may have biased these results. 
Missing values were imputed using chained equations based on 
ALSPAC-G1 adolescent BMI, and characteristics of their moth-
ers (i.e. ALSPAC-G0; educational attainment, home ownership, 
occupational social class, parity, smoking during pregnancy, pre-
pregnancy body mass index, age at birth of their ALSPAC-G1 
child) in addition to all variables in Table 26. For each variable 
with missing data, 100 imputed variables were created. Linear 
regression was used to impute continuous variables, logistic for 
binary, and multinomial logistic for multi-category variables6. 
Differences (differences in means or odds ratios) between charac-
teristics were estimated in each of the 100 imputed datasets and 
then pooled using Rubin’s rules6. The results based on observed 
and imputed data were similar (Table 2).
How often have they been followed-up?
From the start of the study, we established ALSPAC-G2 as an 
open cohort: open both in terms of when someone might enter 
the study (i.e. mothers’ pregnancy, infancy, childhood or later) 
and the length of time we aim to keep recruitment open for 
ALSPAC-G2 (and subsequent generations). We currently have 
protocols for data collection (on both parents (ALSPAC-G1) 
and their offspring (ALSPAC-G2)) for early pregnancy (up to 18 
completed weeks of gestation), late pregnancy (≥28 weeks gesta-
tion), first 7–15 days, 6-months, 12 months, annually up to 7 years 
and then at 9 and 11 years (Figure 3). Our current plans are to 
extend this with protocols for data collection every 2 years up to the 
age of 21 over the next 5-years. We also plan to have just one ‘preg-
nancy’ assessment at any time during pregnancy (see below).
Participants are invited to all subsequent assessments after the 
first one that they attend. Both at recruitment and follow-up 
we are flexible about which assessment age they ‘slot’ into in 
order to maximise response and minimise participant burden, 
particularly when ALSPAC-G1 parents have more than one 
ALSPAC-G2 child. For example, an ALSPAC-G1 woman who 
was recruited when 21 weeks pregnant with a second child and 
who already had a 31-month-old child in ALSPAC-G2, would 
have the pregnancy assessment for their 2nd pregnancy at the 
same time as the next assessment due for the first child. That is, 
we would do the 36-month assessment for the first child a little 
earlier than had their mother not been pregnant with a second child 
to minimise participant burden. The family would subsequently 
be eligible for annual child assessments of the older child and 
birth, 6-months and then annual child assessments of the younger 
child. We would plan all subsequent visits so that the family would 
only need to attend once for each of these subsequent assess-
ments of both children. At all assessments we would complete 
relevant parental and children assessments and within the study 
database record this. For example, at the assessments where 
the mother is pregnant with a second child and also due to have 
a ~36-month postnatal assessment in relation to their first child, 
results would be linked to both children and we would do all 
36-month measurements (that were feasible in a pregnant 
woman), as well as all pregnancy measurements. For the 36-month 
postnatal measurements we would indicate that the woman was 
pregnant with another child.
We have found that we see many ALSPAC-G1 pregnant women 
between the thresholds that we initially used to defined early 
Figure 2. ALSPAC-G2 recruitment from first recruitment (06/06/2012) to 30/06/2018.
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and late pregnancy (i.e. between 20 and 28 weeks of gestation). 
This is because once women contact us to join the study they 
are keen to make an appointment as soon as possible at a date 
that suits them, and also because of combining assessments when 
parents have more than one ALSPAC-G2 child (see example 
description above). We therefore plan to change to having a 
protocol for recruitment at any gestational age in pregnancy and to 
see women just once during pregnancy.
In an open cohort like ALSPAC-G2 in which participants may be 
initially recruited at different ages from when they are in utero 
early in their mother’s pregnancy to late childhood, follow-up 
rates can be difficult to describe. This is because at each of the 
ALSPAC-G2 assessment ages eligible participants include any 
fetus/infant/child who is being recruited and seen for the first 
time at that age and those who were recruited at any of the earlier 
assessment times who have reached the age of the assessment 
under consideration. We summarise this in Figure 4. Taking 
12 months as an example, we can see that over this period, 496 
ALSPAC-G2 participants were eligible for a 12-month assessment 
and of those 31% had been recruited in early pregnancy, 26% in 
late pregnancy, 26% at 6-months and 17% were being recruited 
for the first time at 12 months. In total 405 had been invited by 
June 2018 and of those 323 (80%) were assessed. For the first 
six assessment periods (early pregnancy to 24 months), 71–80% 
of those invited have attended and attendance remains at 60% 
or higher for all assessments up to 7-years. For the two oldest 
ages at which we currently assess ALSPAC-G2 participants, 
9 and 11 years, the proportions are 22% and 80%, respec-
tively. The low response at 9 years was because of delays in 
developing protocols and gaining ethical approval for the later 
assessment periods, which meant that some had become closer 
to 11 years and were seen for the first time at that assessment. 
That said, for both the 9- and 11-year assessments numbers of 
invited participants are low, and the percent assessed less reliable 
than at younger ages.
What has been measured?
We use REDCap software for direct data entry at the point of 
collection. Figure 3 summarises the core data that we currently 
Table 1. Number of participants recruited at different assessment ages.
Participant 
recruitment stage
Number of ALSPAC-G2 recruited at each age by year of recruitment (% recruited at each age by each 
year)
Year 1 
6th June 
2012–30th June 
2013, n (%)
Year 2 
1st July 
2013–30th 
June 2014, 
n (%)
Year 3 
1st July 
2014–30th 
June 2015, 
n (%)
Year 4 
1st July 
2015–30th 
June 2016, 
n (%)
Year 5 
1st July 
2016–30th 
June 2017, 
n (%)
Year 6 
1st July 
2017–30th 
June 2018, 
n (%)
Total recruited 
at each age 
6th June 
2012–30th June 
2018
Early pregnancya 8 (6) 30 (25) 21 (23) 51 (33) 53 (32) 68 (44) 231
Late pregnancya 18 (14) 23 (19) 27 (30) 28 (18) 32 (20) 30 (19) 158
Total pregnancya 24 (20) 53 (44) 48 (53) 79 (51) 85 (52) 98 (63)
7–15 days 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0
6 months 30 (24) 19 (16) 17 (19) 35 (23) 18 (11) 18 (12) 137
12 months 26 (21) 18 (15) 5 (6) 7 (5) 15 (9) 8 (5) 79
24 months 18 (14) 13 (11) 10 (11) 13 (9) 7 (4) 10 (6) 71
36 months 14 (11) 9 (8) 3 (3) 5 (3) 13 (8) 8 (5) 52
48 months 6 (5) 3 (3) 4 (4) 7 (5) 13 (8) 0 (0) 33
60 months 4 (3) 4 (3) 2 (2) 2 (1) 4 (2) 3 (2) 19
6 years 3 (2) 0 (0) 0 (0) 2 (1) 2 (1) 5 (3) 12
7 years 0 (0) 1 (1) 1 (1) 3 (2) 6 (4) 2 (1) 13
9 years 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 4 (3) 5
11 years 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0
Total recruited in 
each year
127 (100) 120 (100) 90 (100) 153 (100) 164 (100) 156 (100) 810
a For the period covered in this paper early pregnancy was defined as up to 18-weeks of complete gestation and later pregnancy as 28- or more weeks. 
However, we have been flexible with these definitions to maximise recruitment and minimise participant burden and found that we see women across 
all gestations (including between 18- and 28-weeks gestation), thus those included in the early pregnancy category will include women up to 23-weeks 
and those as late 24- or more weeks. We are currently changing our protocols to having just one assessment during pregnancy at whatever gestational 
age best suits the woman and her family (see also text in section about how often participants are followed-up). For this reason, we have also provided 
the total numbers and percentage recruited at any time in pregnancy (in italics).
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collect on parents (ALSPAC-G1) and their offspring (ALSPAC-
G2). More detailed lists of variable types are provided in the 
appendices. These list the information collected via question-
naires, clinical assessments, extraction of data from clinical 
records and record linkage, and also list the stored biosam-
ples we have for mothers, fathers and the ALSPAC-G2 children 
(see Extended Data, Summary of data collection)7. 
We collect a range of environmental, social, lifestyle, clinical 
and biological data on all family members repeatedly (Figure 3). 
Biological samples collected routinely include blood (including 
cord-blood), urine, meconium and faeces, and placental tissue. 
Samples are collected with broad generic consent to enable a 
wide range of future use, including genetic analyses. Up to June 
2018, we also invited all relevant mothers (those recruited 
during pregnancy, 6- and/or 12-months postnatal, and who breast-
fed) to provide repeat breast milk samples as part of a pilot 
study to assess response to this request. In total 457 mothers of 
593 children (taking account of siblings and twins) were eligi-
ble and of these, 137 mothers (of 168 children) gave consent to 
participate in this pilot and 105 (of 121 children) have provided 
at least one breast milk sample. Of the 105 mothers who pro-
vided breast milk, 90 gave sample(s) for 1 infant, 14 gave for 
2 infants, and 1 for 3 infants. For any given infant the range of 
samples that have been obtained is 1 to 4 repeats. To date, no 
analyses have been performed on these samples (we would be keen 
to speak to any collaborators who would like to use these sam-
ples). We have also collected, or are collecting, intensive repeat 
or continuously measured data, using novel methods on sub- 
groups, including continuously measured glucose on mothers 
during pregnancy8, videos of parent-child interactions from 
head-worn and home-based cameras9, and dietary intake from 
smart-phone photographs of meals10.
Participant engagement and involvement
We have had active participant groups in ALSPAC since it 
began. These groups suggest areas of data collection and provide 
advice on planned data collection, including methods for collect-
ing these data. In addition, we receive direct advice and sugges-
tions as we collect data (questionnaires or clinic assessments). 
Table 2. Comparison of those recruited and those who have declined or not responded. All results are all from questionnaires, 
research clinic assessments or record linkage data on a ALSPAC-G1 participant who has become pregnant, or for male ALSPAC-G1 
has a partner who has become pregnant or who had become a parent and were eligible to be recruited to ALSPAC-G2 up to 30th June 
2018.
Recruiteda 
(N = 580)
Declined or did not 
respondb 
(N = 447)
Continuous outcomes N (%) 
with data
Mean (SD) N (%) 
with data
Mean (SD) Difference in 
mean (95%CI)c 
Observed 
(complete) data
Difference in mean 
(95%CI)c 
Multivariable imputed 
data
Age (Years)d 580 (100) 22.5 (1.9) 446 (100) 22.8 (1.9) 0.37 (0.13, 0.60) 0.37 (0.13, 0.60)
BMI (Kg/m2)e 467 (81) 26.3 (6.1) 215 (48) 25.4 (5.7) -0.87 (-1.8, 0.1) -0.91 (-0.05, -1.18)
Recruiteda 
(N = 580)
Declined or did not 
respondb 
(N = 447)
Binary outcomes N (%) 
with data
Number with 
the outcome 
(%)
N (%) 
with data
Number with the 
outcome (SD)
Odds ratio 
(95%CI)c 
Observed 
(complete) data
Odds ratio (95%CI)c 
Multivariable imputed 
data
Female 580 (100) 444 (77) 447 (100) 329 (74) 0.85 (0.64, 1.14) No missing data
Educational attainment 
to A-level or higherf
401 (69) 218 (54) 222 (50) 115 (52) 0.9 (0.65, 1.25) 0.88 (0.63, 1.22)
Ever smokedg 509 (88) 336 (66) 252 (56) 170 (67) 1.07 (0.77, 1.47) 1.07 (0.76, 1.49)
Attended 17/18-year or 
24/25-year follow-up
568 (98) 472 (83) 441 (99) 221 (50) 0.2 (0.15, 0.27) 0.2 (0.15, 0.27)
a ALSPAC-G1 participants who were invited and have attended at least one assessment; b ALSPAC-G1 participants who were invited and have declined 
or not responded;
c Differences in means for age and BMI, odds ratios for educational attainment, smoking and attendance at recent clinics, in all analyses those recruited 
are the reference category; d At time of invitation; e At either of the two most recent assessments 24/25 years for those with data from that follow-up, 
otherwise 17/18 years; f A-levels: Advanced-levels, secondary school exams required for University entrance and some other further education/
apprentice schemes taken at age 18. Data obtained from record linkage; g Data from any previous questionnaire (data on smoking have been collected 
repeatedly since age 17 years).
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Figure 3. Summary of data collected on parents and children in ALSPAC-G2. This summarises data collection times and type for the 
period covered by this profile i.e. from initiation of ALSPAC-G2 in June 2012 to the end of June 2018. From Spring 2019 we will be undertaking 
just one assessment during pregnancy and this will be at a time that best suits the pregnant woman.
Figure 4. Summary of eligible and invited participants at each assessment time. Each section in this figure represents one of the 
ALSPAC-G2 age periods (from early pregnancy to 11 years) at which we currently collect data. In each section, for each assessment we 
report the number eligible and the composition of that eligible number based on when they were first invited and recruited to the study (bar 
graph at the top of each assessment period). We also show the total number invited to that assessment and the number and percentage 
of those invited who attended (central figure). All numbers in this figure refer to invites and recruitment between June 2012 and June 2018.
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For ALSPAC-G2, this has included help with collecting and 
appropriately labelling data for same-sex couples and suggesting 
that we collect data on baby-led weaning and helping us to 
develop appropriate questions about this. From age 9 years we 
involve the ALSPAC-G2 children directly via a participant infor-
mation sheet that they (and their parents) helped us to design (see 
Extended Data, Child PIS)7.
What has ALSPAC-G2 found? Key findings and 
publications
Cross-generational comparisons of antenatal and infancy 
characteristics. In pregnant women aged 19–24 years, we have 
shown that the risk of antenatal depressive symptoms is 50% 
higher in young women who were pregnant between 2012 and 
2016, compared with their mother’s generation who were preg-
nant between 1990 and 1992 (relative risk 1.51 [95% confidence 
interval: 1.11, 2.05]), with these findings remaining unchanged 
in numerous sensitivity analyses, including when restricting analy-
ses to 66 mother-offspring pairs11. When individual symptoms 
were examined, the contemporary generation reported notably 
higher levels of feeling overwhelmed, crying often and having 
difficulty sleeping. Offspring of mothers who experienced high 
levels of antenatal depressive symptoms were over three times 
more likely to also experience high levels of symptoms11.
We have undertaken additional preliminary cross-generational 
analyses of pregnancy and perinatal outcomes for this cohort-
profile. In these analyses we only included ALSPAC-G0 women 
who were aged 19–26 at the birth of their ALSPAC-G1, as over 
95% of the ALSPAC-G1 women were within this age range 
when pregnant with their ALSPAC-G2 child. In both groups 
we only included the first pregnancy recruited to the study. For 
these preliminary analyses we have only adjusted for maternal 
age (in years) and we used robust standard errors because of non-
independence between the 197 mother-daughter (ALSPAC-G0-
ALSPAC-G1) pairs across the two groups. We imputed missing 
data using the same method as described above for analyses 
presented in Table 2, except that we used augmented regression 
approach with small weights to prevent perfect prediction for 
smoking variables12.
These preliminary analyses suggest that the current generation 
of pregnant women (ALSPAC-G1 mothers with their G2 child) 
are slightly younger, have a higher body mass index and total 
cholesterol. They also have markedly higher odds of complet-
ing education to at least advanced (A)-level secondary school 
qualifications and markedly lower odds of smoking dur-
ing pregnancy than their mother’s generation (Table 3). 
Their (ALSPAC-G2) children are more likely to be deliv-
ered by Caesarean section, have a higher mean birth weight 
and are more likely to have been breast fed as infants than 
the ALSPAC-G1 generation. Pregnancy haemoglobin lev-
els and gestational age at delivery are similar between 
the two generations (Table 3). We do not have pregnancy glu-
cose levels for the ALSPAC-G0 generation but present these 
for the ALSPAC-G1 generation in Table 3. The results are 
consistent when based on observed data or multivariable imputed 
data.
Pilot data collection of physical activity and diet. We piloted 
the use of a custom made wrist-worn device, which includes 
a triaxial accelerometer sensor, low-power radio, battery and 
non-volatile memory module, on 97 mothers13. The motivation 
was to be able to collect very detailed activity data over extended 
periods of time with as little inconvenience to the participants as 
possible. The device stores accelerometer data in non-volatile 
memory allowing for those data to be retrieved (some time 
later) over a low-power wireless link. It uses a novel, low power, 
lossless data compression algorithm to minimise the amount of 
data transmitted over the radio link, whilst retaining all informa-
tion captured by the accelerometer. This, combined with the low-
power radio, makes it possible to collect very detailed activity 
data whilst minimising overall device power consumption, reduc-
ing the burden of having to keep the device charged13. However, 
the pilot study found that participants were unlikely to wear this 
device because of its large size meaning that they found it less 
‘attractive’ than modern smart watches. We are now collect-
ing pregnancy physical activity levels using the Axivity AX3 
wrist-worn tri-axial accelerometer with a considerably greater 
uptake than the custom made accelerometer (84% versus 50%), 
resulting in those who provided valid data being greater for the 
Axivity AX3 accelerometer (254 (79%) of the 322 eligible) 
compared with the custom-made system (263 (46%) of the 
576 eligible).
We are one of the first studies to explore the feasibility of using 
a smartphone food-photography application to assess dietary 
intake in a general population of young pregnant women10. 
The Remote Food Photography Method (RFPM) collects die-
tary data using the SmartIntake phone application14. Pregnant 
ALSPAC-G1 participants (carrying an ALSPAC-G2 fetus) were 
asked to record 6 days of eating/drinking occasions with this 
smartphone application. Real-time monitoring and feedback 
occurred for the first day. This required them to take a photo-
graph before and after each eating/drinking occasion and provide 
a brief text description of items that are not visible in photos 
(e.g. butter inside sandwiches). A total of 182 mothers who 
were recruited at any assessment point during pregnancy were 
invited to use RFPM and/or an online food diary or recall to 
collect dietary data for 6 consecutive days. A greater propor-
tion of women agreed to use the online method compared with 
RFPM (53% vs 22%). However, of those agreeing to use RFPM, 
more provided data for 4 days or more than those agreeing to 
complete the online diary or recall assessments (58% vs 29%). 
Of those using the RFPM, most found installation and set-up 
(95%), taking photos of meals (70%) and receiving reminders 
(81%) easy or very easy10.
As the use of expert analysis of food photos is extremely research-
resource-intensive, we also completed pilot work comparing 
portion size and food groups identified by expert analysis with 
crowd-sourced data (using photographs from non-ALSPAC 
volunteers). We used 30 photographs of meals. For each of these 
photos total meal weight was measured using an Mandometer® 
device (Mikrodidakt AB, Lund, Sweden) and food groups 
displayed were reviewed by an expert dietitian. In comparison 
to the measured weight, crowds underestimated meal weight 
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by an average of 63 g (95% level of agreement -299 to 174 g), 
whereas the dietitian overestimated by 28 g (95% level of agree-
ment -158 to 214 g)15. In further analyses, we found that compared 
with expert dietician review, crowds varying in size from 5 to 
50 people identified food groups in the photos with high specifi-
city (mean 98%) but modest sensitivity (68%) i.e. crowds almost 
always identified foods in the photo correctly but some foods in 
photos were missed out, explaining the average underestimation 
of total meal weight by crowds (unpublished findings).
Using continuous glucose monitors in unselected prenatal/ 
postnatal women. We have completed a pilot study of the use 
of continuous glucose monitors (CGM) in healthy women 
during pregnancy and postnatally. Women were invited to wear 
a Medtronic iPro2 CGM on their buttock, abdomen or arm, for 
6-days, at up to four time points: in early pregnancy (≤20 weeks 
gestation), late pregnancy (>28 weeks), and at 6 and 12 months 
postnatally. A total of 63 women provided 96 valid sets of CGM 
assessment (25% response), with 41 of these women providing 
Table 3. Comparison of pregnancy, birth and infancy characteristics between pregnancies occurring 1990 to 1992 (parent 
generation; ALSPAC-G0/G1) and those occurring 2012-2018 (contemporary generation; ALSPAC-G1/G2).
Continuous outcomes G0/G1; pregnancies 
1991–1992 
(N = 5,287)
G1/G2; pregnancies 
2012–2018 
(N = 494)
N (%) with 
data
Mean (SD) N (%) 
with data
Mean (SD) Age adjusted 
difference in 
mean (95%CI)a 
Observed 
(complete) data
Age adjusted difference 
in mean (95%CI)a 
Multivariable imputed data
Age at pregnancy/delivery 
(Years)
5287 (100) 23.1 (2.6) 494 (100) 21.7 (2.6) -1.4 (-1.16, -1.64) No missing data
Pregnancy BMI (Kg/m2)b 2719 (51) 23.9 (4.4) 257 (52) 25.1 (5.7) 1.50 (0.77, 2.23) 1.36 (0.69, 2.03)
Pregnancy cholesterol 
(mmol/)
2283 (43) 4.9 (1.5) 133 (27) 6.4 (1.2) 1.6 (1.3, 1.8) 1.5 (1.3, 1.8)
Pregnancy haemoglobin 
(g/dL)
4303 (81) 12.5 (0.9) 285 (58) 12.6 (1.1) 0.08 (-0.06, 0.21) 0.07 (-0.05, 0.20)
Pregnancy glucose (mmol/) NA NA 132 (27) 5.0 (1.1) NA NA
Gestational age (completed 
weeks)e
5287 (100) 39.4 (2.1) 270 (55) 39.38 (2.01) -0.01 (-0.26, 0.24) 0.01 (-0.24, 0.27)
Birthweight (g)e 5217 (99) 3340 (570) 367 (74) 3410 (581) 96 (35, 158) 100 (39, 161)
Binary outcomes G0/G1; pregnancies 
1991–1992 
(N = 5,287)
G1/G2; pregnancies 
2012–2018 
(N = 494)
N (%) with 
data
Number 
with 
outcome 
(%)
N (%) 
with data
Number 
with 
outcome 
(%)
Age adjusted 
Odds ratio 
(95%CI)a 
Observed 
(complete) data
Age adjusted odds ratio 
(95%CI)a Multivariable 
imputed data
Educated to A-level or 
higherc
4410 (83) 827 (19) 321 (65) 175 (54) 7.53 (5.85, 9.7) 7.65 (5.92, 9.88)
Smoked cigarettes in 
pregnancyd
4953 (94) 1948 (39) 210 (43) 33 (16) 0.25 (0.17, 0.36) 0.27 (0.18, 0.39)
Delivered by Caesarean 
Sectione
3245 (61) 453 (14) 274 (55) 53 (19.3) 1.66 (1.20, 2.28) 1.67 (1.22, 2.29)
Ever breastfedd 3779 (71) 2548 (67) 326 (66) 259 (80) 2.18 (1.65, 2.89) 2.20 (1.67, 2.89)
Results are all from the ALSPAC-G0/ALSPAC-G1 (G0/G1) and ALSPAC-G1/ALSPAC-G2 (G1/G2) mother-offspring pairs. G0 women were recruited in 
pregnancy between 1990–1992; G1 are the index female offspring from those pregnancies or the female partners of the index male offspring; G2 are 
their offspring (grandchildren of G0). In both groups only the first pregnancy recruited to the study are included. There was a greater proportion of 
pregnancies removed from G1/G2 (217 out of 711 (31%) than G0/G1 (111 out of 5398 (2%)) reflecting the fact that G1/G2 is an open cohort recruiting 
all children to the original ALSPAC-G1 cohort.
G1/G2 pregnancies occurred between June 2012 and June 2018. For both G0/G1 and G1/G2 analyses are restricted to women who were aged 19–26 years 
during their pregnancy (the age range for the majority of the G1 women when they were pregnant with G2 offspring).
a Difference in mean age unadjusted; all other differences in means or odds ratios adjusted for maternal age. In all analyses G0/G1 are the reference 
category; b For both G0 and G1 women weight was abstracted from the first antenatal clinic visit; height was self-reported for G0 and measured in 
the ALSPAC clinic for G1; c A-levels: Advanced-levels, secondary school exams required for University entrance and some other further education/
apprentice schemes taken at age 18. Education data was obtained from self-report for G0 and 
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data at a single time point (most commonly early or late 
pregnancy), 11 on 2 occasions and 9 on 3 occasions (none 
provided data at all 4 time points)8. While wearing the device, 
participants were asked to measure their capillary blood glu-
cose by finger prick 4 times daily to calibrate the system and to 
record mealtimes in a meal diary. Feedback from participants 
suggests that the requirement to repeatedly test capillary glu-
cose with a finger prick was a disincentive to using this 
system and in Spring 2019 we plan a further study using a 
different system that does not require calibration using capillary 
blood from finger pricks.
We used CGMs to record interstitial glucose ‘continuously’, 
producing a sequence of measurements for each participant 
(e.g. the interstitial glucose every 5 minutes, over a 24-hour 
period for a 6-day period). To analyse these data, researchers tend 
to derive summary variables such as time spent above or below 
specific levels. To date, a lack of consistency and transparency of 
precise definitions used for these descriptive characteristics has hin-
dered interpretation, replication and comparison of results across 
studies16. We have developed an open-source software package 
(GLU) for deriving a consistent set of summary variables from 
CGM data8. GLU performs quality control of each CGM sample 
(e.g. addressing missing data), derives a diverse set of summary 
variables covering six broad domains, and outputs these meas-
ures to the user. We have used GLU with the ALSPAC-G2 
pilot data and shown that overall mean glucose levels were very 
similar (~5 mmol/l) across the four time points, but that this simi-
larity conceals very different patterns of variation, with greater 
variability during pregnancy (both early and late) than postna-
tally and more time spent hypoglycaemic during pregnancy than 
postnatally. Fasting glucose was, on average, higher 12 months 
postnatally compared with early pregnancy8. We also found 
that, during pregnancy, higher BMI was associated with higher 
overall mean glucose levels during both the day and night, 
higher time spent in hyper-glycaemia during the night and 
shorter post-prandial time to peak glucose8.
What are main strengths and weaknesses?
ALSPAC-G2 makes the whole ALSPAC resource a unique inter-
generational scientific resource for researchers globally. Recruit-
ing ALSPAC-G2 provides a pre-conception cohort with very 
detailed information on at least one parent from when they were 
in utero. For the parent who was not a member of the original 
ALSPAC-G1 cohort, extension of our record linkage to primary 
and secondary health care, and school-based educational assess-
ments, will provide some pre-conceptual data, and for those 
with a subsequent child there will be pre-conceptual data on 
the second and subsequent children. ALSPAC-G2 also has 
more data on fathers that in most pregnancy/birth cohorts. An 
additional strength, is that we will use ALSPAC-G2 partici-
pants as a control cohort for local and national clinical cohorts, 
including the on-going national cleft lip and palate cohort, and 
newly planned Bristol IVF and congenital heart disease cohorts. 
We have demonstrated the value of ALSPAC-G2 for piloting 
and testing the feasibility of novel data collection methods and 
work closely with other international birth cohorts to share best 
practice, protocols and replicate, and where appropriate pool data.
Currently the number of ALSPAC-G2 participants is relatively 
small and whilst we have been able to identify large between 
generation differences, such as the difference in antenatal depres-
sion symptoms and smoking during pregnancy, for more mod-
est but potentially important differences it may be some time 
before these can be precisely estimated. That said, participant 
numbers are increasing as the G1 participants approach the cur-
rent mean age for a first pregnancy in the UK (29 years)17. 
At the time we began recruitment, ALSPAC-G1 participants 
were aged 19–21 years and some had already become par-
ents. Thus, whilst the cohort is currently of relatively young 
parents, we do not have detailed pregnancy data on those who 
were pregnant before 19-years (though participants are linked 
to routine health data from which we extract some pregnancy, 
labour and birth data).
There are a number of sources of potential selection bias18. Our 
per cent response is 60% and respondents are more likely to be 
those already engaged with ALSPAC as indicated by being more 
likely to have participated in the two most recent clinic assess-
ments for all ALSPAC-G1 participants. Once recruited a high 
proportion remain actively engaged with follow-up, though 
the extent to which this will continue as the cohort ages and we 
attempt to recruit subsequent generations is unknown (see below). 
Currently, ALSPAC-G2 are children being born to relatively 
young parents; though the age range of parents will increase 
with continued follow-up. Existing data, including on parents 
and grandparents (ALSPAC-G0 and -G1), can be used to explore 
potential selection bias from any of the selection features 
described above, and to inform sensitivity analyses to explore 
the extent of bias that might occur for any given analyses18. We 
would encourage scientists using these data to consider this for 
each analysis they undertake. We try to minimise participant 
burden and hence maximise follow-up by coordinating data 
collection for families with more than one child in ALSPAC-G2 
and as discussed below we also plan to increasingly pilot and use 
remote or passive data collection.
The open nature of the study is a strength as it means we 
will (potentially) capture similar data across the lifecourse 
from in utero to adulthood on all siblings in this generation. 
However, it adds considerable complexity to the study. 
For example, for the preliminary cross-generational analy-
ses presented in Table 3 we only included the first pregnancy 
recruited to either generation. Because ALSPAC-G2 is an open 
cohort in which we aim to include all children of the ALSPAC-
G1 parents, and here we present data from participants recruited 
over a 6-year period (compared with the original recruit-
ment of pregnancies to ALSPAC-G0 over less than 2-years), 
we removed more pregnancies from the ALSPAC-G1/G2 
cohort than the ALSPAC-G0/G1 cohort (31% versus 2%, 
respectively). In future analyses we plan to develop and use 
methods that can analyse all pregnancies as well as use appro-
priate methods for dealing with missing data; we would 
encourage collaborators using these data to also consider its 
multi-level structure (e.g. repeat pregnancies within women 
across generations and potentially including complex family 
structures).
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We anticipate that most ALSPAC-G2 participants will continue 
to be born up to the early 2040s (though as some men con-
tinue to father children into old age, and we recruit all children, 
including some adopted and ‘step’-children, some ALSPAC-G2 
children may be recruited even later than this). By the 
2040s there will also be ALSPAC-G3 and -G4 participants. 
Continuing to recruit these participants and generations adds 
considerable value to the existing ALSPAC resource for the 
whole scientific community. It has the potential to uniquely 
address important research questions related to how development 
and adverse health outcomes are transmitted across generations 
and how we might intervene to maximise population health. 
However, it may be difficult to continue to obtain the nec-
essary funds for continued recruitment of, and data collec-
tion from, multiple generations, and it may also be difficult 
to retain participant engagement over prolonged periods of 
time. To address this, we are pursuing more extensive record 
linkage and novel remote minimally intrusive data capture, such 
as via smart-watches19 and sensors for biomarkers8, to provide 
efficient (and accurate) data collection.
ALSPAC-G2 participants have been recruited at different ages 
and for those recruited after birth, their mother’s pregnancy infor-
mation and their birth/infancy information is limited to what 
we can obtain from record linkage. However, the proportion 
recruited in pregnancy has increased over time. Having an open 
cohort raises questions about when to complete assays on stored 
samples—for example, should we wait until we have 500, 1000, 
or some higher number of cord-blood samples before we assay 
DNA methylation on them? Currently, we invite enquiries about 
using the biosamples and will manage these on a case-by-case 
basis taking account of participant numbers with a given sample, 
risk of disclosure and assay/processing features such as the 
extent of ‘batch’ effects. Our aim is to ensure the resource provides 
the best data for the widest group of scientists.
There are also important considerations about whether we 
should use older data collection tools, such as those used to 
assess mental health and social behaviours in previous ALSPAC 
generations (with the advantage that direct comparisons across 
generations can be made), or more contemporary tools that might 
be considered more valid and allow comparisons with other 
contemporary cohorts. Currently, we have mostly used similar 
tools to those used in the previous generation, but over the 
next 12–24 months we will undertake workshops with experts in 
relevant fields to explore whether there are some measures for 
which we should be using more contemporary tools.
The fact that this is a cohort in which at least one parent has been 
actively engaged with the study for over 20-years may mean that 
they have ‘learnt’ how to respond to some research questions, 
such as those related to mental health, or complete some assess-
ments, such as cognitive function tests20. A ‘learning effect’ will 
be unlikely for direct measurements such as weight, height and 
biosample assays. The ALSPAC-G2 participants are mostly 
born in the South West of England (as were all of the original 
ALSPAC-G1 participants) and are mostly of White European ori-
gin. This has some advantages for exploring between generational 
differences, but we acknowledge replication of findings from 
ALSPAC-G2 with other more diverse cohorts will be important.
Data availability
The ALSPAC data management plan (http://www.bristol.ac.uk/
alspac/researchers/data-access/documents/alspac-data-manage-
ment-plan.pdf) describes in detail the policy regarding data 
sharing, which is through a system of managed open access. The 
steps below highlight how to apply for access to the data included 
in this paper and all other ALSPAC data.
1.    Please read the ALSPAC access policy (PDF, 627kB) which 
describes the process of accessing the data and samples in 
detail, and outlines the costs associated with doing so.
2.    You may also find it useful to browse the fully search-
able ALSPAC research proposals database, which lists 
all research projects that have been approved since April 
2011.
3.    Please submit your research proposal for consideration 
by the ALSPAC Executive Committee. You will receive a 
response within 10 working days to advise you whether 
your proposal has been approved.
If you have any questions about accessing data, please email 
alspac-data@bristol.ac.uk.
We are very keen for ALSPAC-G2 data to be enhanced and used 
by external collaborators and are happy for email queries to D.A. 
Lawlor (d.a.lawlor@bristol.ac.uk) or M. Lewcock (Melanie. 
Lewcock@bristol.ac.uk).
Please note that the study website contains details of all the data 
that is available through a fully searchable data dictionary (http://
www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
Extended data
Details of all of the measurements that are currently being col-
lected on ASPAC-G2 participants and their parents (ALSPAC-G1), 
including the available stored biosamples, alongside the participant 
information sheet that we developed with ALSPAC-G2 children 
for use from age ~9-years, can be accessed on the Open Science 
Framework. DOI: https://doi.org/10.17605/OSF.IO/4APU87.
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